The Essential Knowledge section of the Implants Toolkit is an effort to provide policy makers, program managers, and service providers with the key, or “essential,” background and reference materials on implants. In particular, the document titled, “Essential Knowledge About Hormonal Implants,” under Research Reviews is a thorough summary of the current biomedical, social science, and programmatic knowledge on implants as of February 2010. This document will be updated periodically to reflect new research findings and programmatic knowledge.
The essential resources in this section are up-to-date, accurate and evidence-based, and they include:
Hormonal implants are safe, highly effective, and quickly reversible long-acting progestin-only contraceptives that require little attention after insertion. Clients are satisfied with them because they are convenient to use, long-lasting, and highly effective. This review conducted by the Implants Toolkit Working Group presents the latest biomedical, social science, and programmatic knowledge about hormonal implants as of January 2010.
This document provides answers to frequently asked questions about contraceptive implants, from a description of what they are, how they work, why should my program consider buying them, to programmatic questions, including those about procurement and costs of various implants. Full citations are provided for the sources.
New contraceptive implants are becoming available to family planning programs around the world—the one-rod system Implanon®, the two-rod system Jadelle®, and in some countries Sino-implant (II)®, also two rods. Norplant®, the six-capsule implant system, is no longer be available. The new contraceptive implants hold substantial promise and are likely to broaden the appeal of the method. They are an important option in the range of long-acting methods.
This scientific monograph provides a comprehensive summary of the clinical characteristics of Jadelle levonorgestrel (LNG) rod implants, as observed during clinical trials conducted by the Population Council. The monograph also reviews lessons learned about how to provide Jadelle, based partly on conclusions gleaned from the extensive experience with Norplant, the earlier implant system, and suggests practical ways in which to introduce Jadelle into family planning programs.
2007 | World Health Organization Department of Reproductive Health and Research and Johns Hopkins Bloomberg School of Public Health/Center for Communication Programs | 22 p
The new handbook, Family Planning: A Global Handbook for Providers, offers clinic-based health care professionals in developing countries the latest guidance on providing contraceptive methods. Primary features of the handbook include:
Hormonal implants are a highly effective, very safe, and reversible form of progestin-only contraception that is quickly and easily provided by a trained provider in a few minutes via a minor surgical procedure. This Technical Brief provides an overview of the characteristics of this long-acting method and discusses several programmatic considerations for service delivery.
Produced by Bayer Schering Pharma AG, the manufacturer of Jadelle implants, this brochure provides information about the characteristics of Jadelle, including its duration of use, effectiveness, and mechanism of action.
Comparison of hormonal implants, including manufacturer, formulation, mean insertion and removal time, labeled duration of product use, availability of trocars, per unit cost, cost per year (if used for duration) and WHO prequalification (PQA). Note: 2010 prices.
This peer-reviewed brief provides an overview of contraceptive implants, including effectiveness, current use, manufacturers, registration status, and cost. The goal is to improve information about underused contraceptive methods to improve women's and couple's access to a range of family planning methods.
Sino-implant (II) fact sheet that describes the Gates-funded project to facilitate the introduction of Sino-implant (II) - a low-cost, highly effective contraceptive implant - in resource-constrained countries.
Sino-implant (II) product brochure that provides information about this subdermal contraceptive implant, the manufacturer, approved and planned registrations worldwide, on-going product quality evaluation, distribution agreements and partners, and public sector pricing.
This newlsetter provides an overview of FHI's role in assessing the quality of Sino-implant (II) and in the global introduction of the product. It also includes a summary of the countries in which the method is registered and research updates related to disposable trocars for two-rod implants and cost assessments of Sino-implant (II) compared with other methods.
This brief provides an overview of hormonal implants, including method-specific characteristics, as well as programmatic considerations and lessons learned to increase the success of implants programs.